Citi Starts BridgeBio Pharma (BBIO) at Neutral
Citi analyst Eric Joseph initiates coverage on BridgeBio Pharma (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
